CD8A and neoplasm: PD-1/PD-L1 interactions have been studied in animal models, as well as in vitro, and they have been shown to inhibit the effector functions of tumor-specific CD8+ T cells, thereby contributing to tumor-induced immunosuppression leading to tumor resistance to cytotoxic T cell responses [51–53].